U.S. Banks Stock News

Some investors may be wondering if WEC Energy Group stock at around US$111.67 is offering fair value right now, or if the price is getting ahead of itself. Over the very short term the stock is relatively flat, declining 0.4% over the last week and 3.5% over the last month, while the year to date return sits at 4.9% and the 1 year return at 8.9%, with 3 and 5 year returns of 44.3% and 40.9% respectively. Recent coverage of WEC Energy Group has focused on its position in the regulated...

Genpact (NYSE:G) has been placed in the highest tier by HFS Research for its work in orchestrating and transforming Global Capability Centers. The recognition centers on Genpact's use of AI and platform-led services to support these centers. The ranking underscores the company's role in helping enterprises manage complex operational requirements through Global Capability Centers. For you as an investor, this recognition sits at the intersection of business process management, AI and global...

Shareholders of Bath & Body Works, Inc. ( NYSE:BBWI ) will be pleased this week, given that the stock price is up 18...

It looks like Agnico Eagle Mines Limited ( NYSE:AEM ) is about to go ex-dividend in the next two days. The ex-dividend...

Tyson Foods, Inc. ( NYSE:TSN ) is about to trade ex-dividend in the next two days. The ex-dividend date is one business...

BorgWarner Inc. ( NYSE:BWA ) is about to trade ex-dividend in the next two days. The ex-dividend date is one business...

Q1 2026 earnings snapshot sets the stage for Autohome (NYSE:ATHM) Autohome (NYSE:ATHM) opened 2026 with Q1 revenue of C¥1,048.4 million and basic EPS of C¥0.38, alongside net income of C¥44.3 million, putting fresh numbers behind a stock currently trading at $17.30. Over the last few quarters, revenue has moved from C¥1,783.4 million in Q4 2024 to C¥1,453.8 million in Q1 2025 and then to C¥1,048.4 million in Q1 2026, while quarterly basic EPS has shifted from C¥2.51 to C¥2.86 and then to...

Wondering if Sociedad Química y Minera de Chile at around US$84.05 is still offering value after a strong run, or if you are arriving late to the story. The stock has returned 6.0% over the past week, is down 6.0% over the past month, but is up 20.5% year to date and 169.1% over the last year, which can change how the market is thinking about its risk and reward profile. Recent coverage has focused on Sociedad Química y Minera de Chile as a key player in materials and lithium related themes,...

Agilent Technologies (A) has just reported Q2 2026 results with revenue of US$1,835 million and basic EPS of US$1.20, alongside trailing twelve month revenue of US$7.2 billion and EPS of US$5.00 that sit against a one year earnings growth figure of 21.3%. Over recent quarters, revenue has ranged between US$1,668 million and US$1,861 million while quarterly EPS has moved between roughly US$0.75 and US$1.53, with net profit margin across the last year at 19.6% compared to 17.6% a year earlier...

Momentus (MNTS) has drawn fresh attention after entering securities purchase agreements with existing institutional investors for a private placement of 2,942,000 shares. The transaction is expected to raise about US$25,000,000 in gross proceeds. See our latest analysis for Momentus. The private placement and recent shelf registrations have arrived after a sharp swing in sentiment, with the 30 day share price return of 278.91% and year to date share price return of 237.98% contrasting with a...

Investors may wish to note that the Chief Revenue Officer of TechTarget, Inc. , Steven Niemiec, recently netted US$95k...

Wondering if Forgent Power Solutions at around US$47.56 is offering value or stretching expectations? This article walks through what the current price might be telling you. The stock has eased about 2% over the past week, but is still up 28.9% over the past month and 64.0% year to date, which can change how you think about both upside and risk. Recent coverage has focused on Forgent Power Solutions as investors look more closely at power and grid related companies, with attention on how its...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Why National Beverage stock is drawing attention National Beverage (FIZZ) is back on investors’ radar after a recent share price move, with returns over the past month and past 3 months prompting closer scrutiny of its fundamentals and valuation. See our latest analysis for National Beverage. At a recent share price of US$37.24, the stock has a 1 month share price return of 7.91% and a year to date share price return of 17.62%, yet the 1 year total shareholder return is down 16.95%. This...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Garrett...

Wondering if Vulcan Materials at a recent US$276.75 close is priced appropriately for its future or offering limited value? This article walks through what the numbers actually say about the stock. Recent returns have been mixed, with the stock up 5.6% over the past week, down 5.0% over the past month, down 5.4% year to date, and up 5.1% over the past year, which can signal changing views on both opportunity and risk. Recent news flow around Vulcan Materials has centered on ongoing interest...

The United States market has shown robust performance recently, climbing 1.8% in the last seven days and rising 28% over the past year, with earnings forecasted to grow by 17% annually. In this thriving environment, identifying small-cap stocks that are potentially undervalued and experiencing insider action can present unique opportunities for investors seeking to capitalize on growth prospects within emerging companies.

EyePoint Pharmaceuticals recently presented at the Stifel 2026 Virtual Ophthalmology Forum and reiterated that top-line Phase 3 data for its wet age-related macular degeneration (AMD) therapy DURAVYU are expected to begin reading out in August, with a second pivotal trial to follow about two months later. Management highlighted 2026 as potentially transformative, emphasizing ambitions for DURAVYU to match a leading therapy on vision outcomes while maintaining safety and reducing treatment...

Lantheus Holdings (NasdaqGM:LNTH) plans to present new clinical data for LNTH-2403, an LRRC15-targeted radiopharmaceutical, at the 2026 ASCO Annual Meeting. The company will also share real-world data on piflufolastat F 18 imaging use in early-stage prostate cancer at the same conference. These updates provide fresh detail on both Lantheus's osteosarcoma pipeline and the adoption of its approved prostate cancer imaging agent. Lantheus focuses on radiopharmaceuticals and imaging agents used...

Over the last 7 days, the United States market has risen 1.8% and in the past year, it has climbed 28%, with earnings expected to grow by 17% per annum over the next few years. In this environment, identifying high growth tech stocks involves looking at companies that not only show strong potential for revenue expansion but also align well with these positive market trends.

Capital One Financial (NYSE:COF) is moving Discover’s credit card portfolio onto Capital One’s own back-office platform as part of the merger process. The integration focuses on consolidating technology systems and operational processes used to service and process Discover credit card accounts. The back-office migration is expected to influence cost efficiency, revenue opportunities, and how the combined company competes in card processing. For you as an investor, this move sits at the...

The United States market has shown robust performance, rising 1.8% over the last week and climbing 28% in the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying stocks that are trading below their estimated value can offer potential opportunities for investors looking to capitalize on market growth while minimizing risk.

COMPASS Pathways (NasdaqGS:CMPS) has appointed Kathleen Tregoning to its Board of Directors. Tregoning brings extensive biotech and pharmaceutical leadership experience, including roles at Cerevel Therapeutics and other large drugmakers. The appointment is intended to support COMPASS Pathways as it advances late stage programs and prepares for potential commercialization. For investors tracking mental health treatment companies, COMPASS Pathways focuses on developing therapies for...

Anyone interested in Rigetti Computing, Inc. ( NASDAQ:RGTI ) should probably be aware that the Chief Technology...